바로가기  >

Abstract
Purpose: This study investigated whether hypofractionated adjuvant radiotherapy (RT) increased breast-related complication(s) compared to conventional fractionated RT in reconstructed breast cancer patients.

Methods: We conducted a retrospective review including 349 breast cancer patients who underwent immediate breast reconstruction following mastectomy or breast-conserving surgery (BCS) between 2009 and 2018 at two institutions. All patients were treated with adjuvant RT via either a conventional fractionated or hypofractionated regimen. We defined a major breast complication as a breast-related toxic event requiring re-operation or re-hospitalization during the follow-up period after the end of RT.

Results: The median follow-up was 32.3 months (4.8-118.5 months); 126 patients had conventional fractionated RT, and 223 patients received hypofractionated RT. In patients with mastectomy, there was no significant difference in the occurrence of any or major breast-related complications between the two fractionation regimens. In patients undergoing BCS, incidence of any breast complication showed no difference between two RT groups and no major breast complication was reported as well. Hypofractionated RT did not increase major wound problem (infection and dehiscence) compared to conventional RT. Incidence of major contracture was significantly lower in hypofractionated RT.

Conclusions: There was no significant difference in the occurrence of any or major breast-related complications between the two different fractionation regimens, even in patients with mastectomy. Hypofractionated RT may be used comparable to conventional fractionated RT in terms of breast-related complications in reconstructed breast cancer patients. The prospective randomized trial would be necessary to clarify this issue.

Fig 1

유방전절제술을 받은 환자에서, 방사선 치료 분획에 따라 any breast complication의 발생에 유의한 차이가 없었고 (P=0.064), any breast complication 중 재입원 혹은 재수술이 필요했던 Major breast complication의 발생 또한 유의한 차이가 없었다 (P=0.420).

Fig 2

유방보존술을 받은 환자에서, 방사선 치료 분획에 따라 any breast complication 발생에 유의한 차이가 없었다 (P=0.301). 유방보존술을 받은 경우 major breast complication의 발생은 없었다.

Affiliations

Dong-Yun Kim  1 , Eonju Park  2 , Chan Yeong Heo  2 , Ung Sik Jin  2 , Eun Kyu Kim  3 , Wonshik Han  4 , Kyung Hwan Shin  1 , In Ah Kim  5
1 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
2 Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
3 Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
4 Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University, College of Medicine, Seoul, Republic of Korea.
5 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University, College of Medicine, Seoul, Republic of Korea; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. Electronic address: inah228@snu.ac.kr.